SCHEMBL28684686

SCHEMBL28684686

CCOC(=O)c1cnc(Cl)nc1NCCC(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
SYK P43405 3/20 0.48
SLC26A6 Q9BXS9 1/20 0.47
KDM4E B2RXH2 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
SIRT5 Q9NXA8 7/20 0.43
NPSR1 Q6W5P4 2/20 0.42
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18168237 0.88 PDE4B (0.50) ALDH1A1SYKKDM4ECYP1A2CYP3A4
SCHEMBL22866255 0.87 ALDH1A1 (0.55) ALDH1A1SYKKDM4ECYP1A2CYP3A4
SCHEMBL2523948 0.84 SYK (0.53) ALDH1A1SYKKDM4ECYP1A2CYP3A4
SCHEMBL11582962 0.84 ALDH1A1 (0.52) ALDH1A1SYKKDM4ECYP1A2CYP3A4
SCHEMBL17764556 0.82 SYK (0.51) ALDH1A1SYKKDM4ERAB9ANPC1
SCHEMBL22261163 0.82 JAK3 (0.55) SYKCYP1A2JAK2JAK1TYK2
SCHEMBL29076116 0.81 ALDH1A1 (0.49) ALDH1A1SYKKDM4ECYP1A2CYP3A4
SCHEMBL23620399 0.80 SYK (0.54) ALDH1A1SYKKDM4ENPC1MEN1
SCHEMBL14810384 0.80 KDM4E (0.57) ALDH1A1SYKKDM4ENPC1MEN1
SCHEMBL654492 0.80 SYK (0.49) ALDH1A1SYKKDM4ERAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113801139-A Pyrimido-oxazine derivatives as RSK inhibitors and uses thereof 华东理工大学 2021-12-17 CN disclosed